Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 801–900 of 965
Microbiota–modulated enteric neuron translational profiling uncovers a CART+ glucoregulatory subsetPreprint
Muller, P. A., Schneeberger, M., Matheis, F., Kerner, Z. J., & Mucida, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.09.983841 · Cited by 1
“The gut microbiota influences several physiological and pathological processes, including local nutrient absorption and lipid metabolism (7, 44-49), as well as activation of the gut–associated and systemic immune system (50).”
BackgroundUtilities start power cutbacks
van Ruth, P., & Schroeder, C. H. (1978) · Energy User News; (United States)
Glucose supplementation impacts lifespan and immunity in Drosophila melanogaster
Galenza, A. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-vcpw-fj52
Erhöhte Darmpermeabilität: Pathomechanismus für metabolische Erkrankungen?
Patt, M., Massier, L., Kovacs, P. L., Blüher, M., & Chakaroun, R. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00726-y · Cited by 1
Исторический анализ сущности понятия «Реабилитация» в системе специального образования
Зак, Г. Г. (2012) · Специальное образование
Cai, S., Li, J., & Zhang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-280189/v1
“Pathogen and its metabolites might contribute to in ammation and diabetes development [4].”
BackgroundInfluentialThe Role of Diet and Exercise in the Gut Microbiota and Metabolism
Chandra, A. (2021) · eScholarship (California Digital Library)
Abellán, R. M. (2008) · Revista iberoamericana de psicomotricidad y técnicas corporales
Probiotics and the gut-brain axis
Silveira, A. K., Gasparotto, J., & Moreira, J. C. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85170-1.00001-4
Fungal Infections Complicating COVID-19
Hoenigl, M., & Talento, A. F. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0555-8
Obesity; Its Prevalence, Consequences and Potential Therapies
Sharma, T., Salah, H. M., Turaga, N. S. S., & Mehta, J. L. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-84763-0_12
Wang, L., Yang, M., Wu, C., Hu, H., Ji, L., Lai, R., Peng, M., & Huang, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1512054/v1
Dietary components associated with being overweight, having obesity, and cancer
Anisman, H., & Kusnecov, A. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91904-3.00018-5
Sukmarindra, A., Santoso, P., & Ilmiawati, C. (2000) · IALLT Journal of Language Learning Technologies · doi:10.17161/iallt.v32i1.8305
Adaptation of Gut Microbiota to Modern Dietary Sugars and Sweeteners
李, 梦. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1291193
Markers of Bacterial Translocation in Type 2 Diabetes Mellitus
Meheissen, M. A. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_49
Porphyromonas gingivalis, ethanol, and chronic diseases.
Short, N. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3824 · Cited by 1
Manipulation of Epigenome: Opportunities and Pitfalls in Fighting Autoimmune Diseases
Higazi, H., Khan, F. A., Ali, S., Mohamed, S. E. R., Pandupuspitasari, N. S., Yousif, A., & Kandakurti, P. (2022) · International Journal of Biomedicine · doi:10.21103/article12(4)_ra2
The gut microbiota: A driver of Type 2 diabetes
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Paneque, A. A. E., Ortiz, M. G. C., Maldonado, E. A. D., Matute, S. G. U., Martínez, C. E. C., & Llumiquinga, P. M. Q. (2022) · doi:10.58594/dzdk6465
Jamilah, N. S. (2020) · Chula Digiverse · doi:10.58837/chula.the.2020.474
“Therefore, high amount of LPS influx may exacerbate current inflammation conditions in diabetes type II individuals (Thaiss et al., 2018).”
BackgroundMaldini, A. C., Calvo, M. L., Schlinder, A., HEREDIA, V. V. O., Marco, R. D., Forlin, G. M. E., González, J. P., Apoloni, S. B., Burgos, M. A., López, C. E., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v57i1.680
Kang, X., Liu, S., & Ludvigsson, J. F. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17518
Insulinización en adultos mayores con diabetes mellitus tipo 2
Herrera, K. R. S., & Ayala, L. M. C. (2023) · ConcienciaDigital · doi:10.33262/concienciadigital.v6i4.2696
Gut microbiota and metabolic syndrome: What's new?
Saberi‐Karimian, M., Bana, H. S., Fazeli, M., Tabatabaeizadeh, S., Ferns, G. A., & Ghayour‐Mobarhan, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00050-5
Régulation et fonctions du facteur de transcription ChREBP dans l'épithélium intestinal
Charifi, W. (2021) · theses.fr (ABES) · doi:10.70675/89543c3fz31abz4d56zaa7bz77c2c07ffd69
Cancer in diabetes: Who is who?
García‐Jiménez, C., García-Martínez, J. M., & Chocarro‐Calvo, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00003-8
Huang, X.-M., Lei, L., Feng, F., & Shao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22606130
Li, Z., Chen, H., & Chen, T. (2022) · Figshare · doi:10.6084/m9.figshare.21273841
Relationship Between Chronic Kidney Disease and Diabetic Foot Ulcers
Zhang, Y., & Li, Y. (2024) · Journal of Clinical Medicine Research · doi:10.32629/jcmr.v5i1.1804
“Urinary toxins and hyperglycemia lead to the damage of intestinal epithelial cells and the destruction of barrier function in patients, thus increasing the systemic inflow of microbial products and the spread of intestinal infection[25] [26].”
BackgroundDie Bedeutung des Darmes und der Mikrobiota bei viralen Krankheiten und Epidemien
Fegerl, S. P. (2024) · Springer eBooks · doi:10.1007/978-3-662-67508-3_8
METABOLIC ACTIVITY OF MICROBIOTA OF THE COLON IN RATS WITH EXPERIMENTAL DIABETES
Ткачук, О. В., Тkachuk, S. S., Hryniuk, M. I., Denysenko, O. I., Гарвасюк, О., & Sоrokhan, V. D. (2024) · Clinical & experimental pathology · doi:10.24061/1727-4338.xxiii.2.88.2024.11
“Збільшення проникності кишкового бар ’ єру під впливом гіперглікемії відбувається через GLUT2-залежне транскрипційне перепрограмування епітеліальних клітин кишечнику і зміну цілісності щільних з ’ єднань [8].”
Duttaroy, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95700-7.00015-2
Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?
Sionov, R. V., & Steinberg, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00017-2
Syndrome of increased intestinal permeability in type 1 and type 2 diabetes mellitus
Dvoryanchikov, Y. V., Deunezhewa, S., Beloglazov, V. A., & Yatskov, I. A. (2024) · Obesity and metabolism · doi:10.14341/omet13027
Prebiotics, Probiotics, Symbiotics and Postbiotics. Nutrition and Microbiota
Ruíz-Tóvar, J., & Llavero, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-65650-7_2 · Cited by 1
Mikrobiom und MASLD, Leberzirrhose und Leberkarzinom
Stadlbauer, V. (2024) · Springer eBooks · doi:10.1007/978-3-662-68455-9_11
Huizinga, G. P. (2024) · Deep Blue (University of Michigan) · doi:10.7302/25035
Fang, Q., Chen, C., Li, Z., & Tan, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21630-5.00004-6
NK cell development and functional response during nonalcoholic steatohepatitis
Bourayou, E. (2023) · theses.fr (ABES) · doi:10.70675/9bf510f6z9823z4aaaza4bczb276b50278c4
The Role of Microbiome in Metabolic Pattern Changes
Akool, E., Shatat, A.-A. S., & Balah, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_13
The Role and Mechanism of Gut Microbiota in the Development of Diabetic Nephropathy
韩, 梅. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152336
Stancu, P., Janela, D., Gurary, S. T., Sveikata, L., & Assal, F. (2025) · Clinical and Translational Neuroscience · doi:10.3390/ctn9010008
“Furthermore, hyperglycemia may indirectly contribute to delirium by affecting the gut microbiome and increasing intestinal permeability [14,15].”
Tang, T. W.-H., Pasaribu, S. N. N., Chen, H.-C., Lin, P.-J., Ruan, S., Wissel, E. F., Kuo, C., Chen, P., Ho, Y., Chang, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.26.640249
Tremoulis, D. C., Papadopoulou, G., Pogka, V., Argyraki, A., Lourida, P., Mentis, A. F., & Karamitros, T. (2025) · Pathogens · doi:10.3390/pathogens14040381
Sholikah, T. A., Septyaningtrias, D. E., Sumiwi, Y. A. A., Muthmainah, M., Nyengaard, J. R., & Susilowati, R. (2025) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2025.152666
PrayGod, G., Kweka, B. V., MALINDISA, E. K., Rehman, A. M., Frikke‐Schmidt, R., Christoffersen, C., Krogh‐Madsen, R., Faurholt‐Jepsen, D., Friis, H., Kelly, P. M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327166
Rihane, R., Hecini-Hannachi, A., Hasnaoui, B., Bentchouala, C., Benlabed, K., Rolain, J., & Diene, S. M. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107897
Sun, H.-F., Yang, T., Liu, Y., Kang, D.-N., Zhu, G., Zhou, Q., Yin, Y.-L., Hou, X.-D., Tang, H. R., & Hou, J. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106790
Role of gut microbiota, probiotics and prebiotics in diabetes
Soni, M., & Dwivedi, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33351-4.00021-0
Carvalho, V. F., Faria‐Melibeu, A. D. C., Gomes, A. L. T., Neves, L. D. S., & Campello‐Costa, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27370-4.00001-9
Singh, V., Lin, R., Sunuwar, L., Yang, J., Donowitz, M., & Sarker, R. I. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00590.2025
Yang, X. H., Zhang, J., Xie, X. S., & Tang, W. (2025) · PeerJ · doi:10.7717/peerj.20070
“…( Oliver et al., 2022 ; Wand et al., 2022 ); on the other hand, the level of opportunistic Enterobacteriaceae in diabetic patients is high, and the intestinal barrier function is decreased, resulting in an increased risk of pathogen transmission ( Anhê et al., 2020 ; Thaiss et al., 2018 ).”
Research Progress on the Synergy Mechanism of Dietary Fiber and Prebiotics
Zhao, H. (2025) · International journal of agriculture and food sciences research. · doi:10.62051/ijafsr.v3n2.04
“In people with diabetes 2 mellitus (T2DM), research has found that serum zona occludens (ZO)-1, indicating increased intestinal permeability and the existence of "intestinal leakage" [5].”
Treveeravoot, S., Sukmak, P., Chatkul, P., Arinno, A., Amonsiriwit, S., Supapol, P., Limwattananon, T., Choksukchalalai, N., Kitti-udom, N., Chindaduangratn, N., et al. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2585726
Research Progress on the Pathogenesis of Diabetic Foot
曹, 瑞. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15113223
Ендокринопатії та їх зв’язок з мікробіотою кишки
Moskva, K. A. (2025) · Primedia eLaunch LLC eBooks · doi:10.36074/ezmk.textbook-2025
Endocrinopathies and their connection with the gut microbiota
Moskva, K. A. (2025) · Primedia eLaunch LLC eBooks · doi:10.36074/ecgm.textbook-2025
Michurina, S. V., Serykh, A. E., Ishchenko, I. Y., Arkhipov, S. A., Letyagin, A. Y., Korolev, M. A., Rachkovskaya, L. N., & Zav’yalov, E. L. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093025060055
Parantainen, J., Barreto, G., Koivuniemi, R., Kautiainen, H., Nordström, D., Moilanen, E., Hämäläinen, M., Leirisalo-Repo, M., Nurmi, K., & Eklund, K. (2022) · Figshare · doi:10.6084/m9.figshare.21591098
Eraqi, W. A., El‐Sabbagh, W. A., Aziz, R. K., Elshahed, M. S., Youssef, N. H., & Elkenawy, N. M. (2024) · Figshare · doi:10.6084/m9.figshare.26751670
Parantainen, J., Barreto, G., Koivuniemi, R., Kautiainen, H., Nordström, D., Moilanen, E., Hämäläinen, M., Leirisalo-Repo, M., Nurmi, K., & Eklund, K. (2022) · Figshare · doi:10.6084/m9.figshare.21591110
Deciphering the role of the gut microbiota in murine MASH and MASH-to-HCC transition
Schühle, S. (2024) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00034638
Jingwen, Q., Wu, J., Chen, W., Ruan, Y., Mao, J., Li, S., Tang, X., Zhao, L., Li, S., Li, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25200606
Huang, Z., Teng, W., Yao, L., Xie, K., Hang, S., He, R., & Li, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26710508
Montenegro, R. M., Ponte, C. M. M., Castelo, M. H. C. G., de Oliveira Silveira, A. C., Fernandes, V. O., d’Alva, C. B., Oliveira, L. F. V., Hristov, A. D., Bandeira, S. P., da Cruz Paiva, G. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21205394
Parantainen, J., Barreto, G., Koivuniemi, R., Kautiainen, H., Nordström, D., Moilanen, E., Hämäläinen, M., Leirisalo-Repo, M., Nurmi, K., & Eklund, K. K. (2022) · Figshare · doi:10.6084/m9.figshare.21591107
Montenegro, R. M., Ponte, C. M. M., Castelo, M. H. C. G., de Oliveira Silveira, A. C., Fernandes, V. O., d’Alva, C. B., Oliveira, L. F. V., Hristov, A. D., Bandeira, S. P., da Cruz Paiva, G. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21205403
Parantainen, J., Barreto, G., Koivuniemi, R., Kautiainen, H., Nordström, D., Moilanen, E., Hämäläinen, M., Leirisalo-Repo, M., Nurmi, K., & Eklund, K. K. (2022) · Figshare · doi:10.6084/m9.figshare.21591101
Learning on the fly: Adverse effects of high sugar diets and metabolic consequences of infection
Darby, A. M. (2024) · eCommons (Cornell University) · doi:10.7298/shc1-zg23
Li, Z., Chen, H., & Chen, T. (2022) · Figshare · doi:10.6084/m9.figshare.21273844
Montenegro, R. M., Ponte, C. M. M., Castelo, M. H. C. G., de Oliveira Silveira, A. C., Fernandes, V. O., d’Alva, C. B., Oliveira, L. F. V., Hristov, A. D., Bandeira, S. P., da Cruz Paiva, G. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21205406
Parantainen, J., Barreto, G., Koivuniemi, R., Kautiainen, H., Nordström, D., Moilanen, E., Hämäläinen, M., Leirisalo-Repo, M., Nurmi, K., & Eklund, K. K. (2022) · Figshare · doi:10.6084/m9.figshare.21591104
Montenegro, R. M., Ponte, C. M. M., Castelo, M. H. C. G., de Oliveira Silveira, A. C., Fernandes, V. O., d’Alva, C. B., Oliveira, L. F. V., Hristov, A. D., Bandeira, S. P., da Cruz Paiva, G. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21205400
Montenegro, R. M., Ponte, C. M. M., Castelo, M. H. C. G., de Oliveira Silveira, A. C., Fernandes, V. O., d’Alva, C. B., Oliveira, L. F. V., Hristov, A. D., Bandeira, S. P., da Cruz Paiva, G. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21205397
Li, T., Han, B., Wang, L., Sun, L., Cai, Y., Yu, M., Xiao, W., & Yang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26669688
The role of dietary composition on metabolic health of the gut-liver axis
Mushtaq, A. (2021) · UEA Digital Repository (University of East Anglia) · Cited by 1
Bégin, F. (2021) · Corpus Université Laval (Université Laval)
Nogueira, S. J. D. S. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/g7e9-a831
Research Progress on Biodegradable Polymer Materials for Oral Insulin Delivery
Su, Y. X., Li, Z. L., Gao, H. X., & Xiong, X. Y. (2025) · Polymer Science Series A · doi:10.1134/s0965545x24601333
Liu, H., Liu, S., Zhang, Q., Zhang, S., Zhu, S., & Wu, S. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251383796
Yatskov, I. A., Beloglazov, V. A., Ageeva, E. S., Николаевна, Р. И., & Ulyanova, D. I. (2025) · Problems of Balneology Physiotherapy and Exercise Therapy · doi:10.17116/kurort202510206126
Microbiota in Food Sensitivities and Allergies
Lokeshwari, B., Saranraj, P., Arthi, K., Gayathri, K., Kesavardhini, K., & Manigandan, M. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4382-2.ch007
Low-grade chronic inflammation in obesity: biomarkers and clinical perspectives
Gómez, M. G. (2024) · UCrea (University of Cantabria)
TAS2R46 activation protects intestinal barrier from chronic high glucose
Wang, J., Tian, S., Duan, J.-Y., Zhang, C.-P., & Liu, Y.-W. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106516
Rijjal, D. A. (2022) · TSpace (University of Toronto)
Emrich, R. P. S., Bueno, G. F., dos Santos, W. M., Pereira, A. B. M., Andrade-Silva, L. E., Neto, J. B. C., Silva, P. R. D., Silva-Vergara, M. L., & Rogério, A. D. P. (2025) · Acta Biologica Brasiliensia. · doi:10.18554/acbiobras.v8i2.8766
Vasudevan, D. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i3.113843
Kusch, J., Argyropoulos, T., Goumas, K., Tribonias, G., Reppas, C. I., & Vertzoni, M. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107513
Martínez-Ruiz, M., Tabor‐Simecka, L., Graham, J. L., Randolph, C., Fox, R., Lan, R. S.-L., Pack, L., LeRoith, T., Stanhope, K. L., Yeruva, L., et al. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2025
Association between total dietary sugar intake and gallstones in Americans
Zhang, J., Lu, Y., Zhou, X., & Cheng, G. (2026) · Scientific Reports · doi:10.1038/s41598-026-44407-6
Rooyen, D. M. V., Cai, M., Nair, B. R., & Talley, N. J. (2026) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2026.2651944
“Furthermore, chronic hyperglycemia has been shown to impair intestinal permeability and increase the susceptibility to gastrointestinal infections [34].”
Role du fructose dans la physiopathologie du syndrome de l'intestin irritable
Melchior, C. (2018) · theses.fr (ABES) · doi:10.70675/b07649edz908dz4d73za666z0112bc94cdf8
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.